IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Euclidean Capital LLC

Q2 2021 Holdings

Filed 2021-08-16 | 14 holdings | $24.7M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2021-11-15) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Alector Inc(ALEC)COM014442107$20.4M980,89482.6%
Beam Therapeutics Inc(BEAM)COM07373V105$4.0M31,13116.2%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$133.5K3,908,6770.5%
23Andme Holding CoCLASS A COM90138Q108$119.7K10,243,1190.5%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$29.4K1,493,3490.1%
Denali Therapeutics Inc(DNLI)COM24823R105$25.4K323,7490.1%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$23.4K735,8010.1%
Constellation Pharmceticls I(CNST)COM210373106$18.7K554,3250.1%
Oric Pharmaceuticals Inc(ORIC)COM68622P109$17.6K996,7340.1%
Foghorn Therapeutics Inc(FHTX)COM344174107$13.5K1,261,2610.1%
Snowflake Inc(SNOW)CL A833445109$11.4K47,1360.0%
First Finl Bancorp OH(FFBC)COM320209109$4.1K173,5760.0%
Nurix Therapeutics Inc(NRIX)COM67080M103$4.1K154,4260.0%
Pinduoduo Inc(PDD)SPONSORED ADS722304102$1.2K9,8060.0%
VIR Biotechnology Inc(VIR)COM92764N102$1.2K25,8660.0%